Intellia Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.About NTLA
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.
NTLA Key Statistics
NTLA News
Citizens JMP analyst Silvan Tuerkcan upgraded Intellia Therapeutics (NTLA) to Outperform from Market Perform with a $33 price target The firm’s survey of North...
Intellia Therapeutics recently announced results from its ongoing Phase 1 study, showing deep and lasting serum TTR reductions with evidence of clinical improve...
Insiders have been trading these 5 stocks: ((CRWV)), ((SMR)), ((SO)), ((NTLA)) and ((PSEC)). Here is a breakdown of their recent trades and their value. Elevate...
Analyst ratings
81%
of 26 ratingsMore NTLA News
New insider activity at Intellia Therapeutics ( (NTLA) ) has taken place on October 3, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premi...
Interest in Intellia Therapeutics (NTLA) has been picking up following fresh long-term data for its lead gene-editing program, nexiguran ziclumeran, as well as...
20:32 EDT Cathie Wood’s ARK Investment buys 99K shares of Intellia Therapeutics (NTLA) today Published first on TheFly – the ultimate source for real-time, mar...